切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 doi: 10.3877/cma.j.issn.2095-3232.2024044

专家论坛

胆囊癌辅助诊断研究进展
郑大雯1, 王健东1,()   
  1. 1. 200092 上海交通大学医学院附属新华医院普通外科
  • 收稿日期:2024-05-24
  • 通信作者: 王健东
  • 基金资助:
    上海市2021年度"科技创新行动计划"医学创新研究专项面上项目(21Y11912400)

Research progress in adjuvant diagnosis of gallbladder cancer

Dawen Zheng1, Jiandong Wang1,()   

  1. 1. Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
  • Received:2024-05-24
  • Corresponding author: Jiandong Wang
引用本文:

郑大雯, 王健东. 胆囊癌辅助诊断研究进展[J]. 中华肝脏外科手术学电子杂志, doi: 10.3877/cma.j.issn.2095-3232.2024044.

Dawen Zheng, Jiandong Wang. Research progress in adjuvant diagnosis of gallbladder cancer[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), doi: 10.3877/cma.j.issn.2095-3232.2024044.

胆囊癌恶性程度高,预后差。由于其早期无典型临床症状和解剖结构的特点,大部分胆囊癌患者确诊时肿瘤至中晚期,无根治性手术机会。目前临床上仍缺乏特异性的胆囊癌辅助诊断方法。本综述旨在简要概述当前胆囊癌研究领域中所采用的辅助诊断方法及包括液体活检在内的相关研究进展,以期为未来胆囊癌的精准诊断与治疗提供有益的参考。

Gallbladder cancer has high-degree malignancy and poor prognosis. Due to atypical clinical symptoms and anatomical structures during the early stage, most patients are diagnosed with moderate and advanced gallbladder cancer upon admission, losing the opportunity for radical resection. At present, specific adjuvant diagnostic method is still lacking for gallbladder cancer in clinical practice. In this article, research progress in adjuvant diagnostic methods for gallbladder cancer including liquid biopsy was briefly reviewed, aiming to provide useful reference for accurate diagnosis and treatment of gallbladder cancer in the future.

[1]
Randi G, Franceschi S, la Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors[J]. Int J Cancer, 2006, 118(7):1591-1602.
[2]
Kalra N, Suri S, Gupta R, et al. MDCT in the staging of gallbladder carcinoma[J]. AJR Am J Roentgenol, 2006, 186(3):758-762.
[3]
Lee SE, Kim KS, Kim WB, et al. Practical guidelines for the surgical treatment of gallbladder cancer[J]. J Korean Med Sci, 2014, 29(10):1333-1340.
[4]
Miyakawa S, Ishihara S, Horiguchi A, et al. Biliary tract cancer treatment: 5, 584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in Japan[J]. J Hepatobiliary Pancreat Surg, 2009, 16(1):1-7.
[5]
Pawlik TM, Choti MA. Biology dictates prognosis following resection of gallbladder carcinoma: sometimes less is more[J]. Ann Surg Oncol, 2009, 16(4):787-788.
[6]
Macias RIR, Banales JM, Sangro B, et al. The search for novel diagnostic and prognostic biomarkers in cholangiocarcinoma[J]. Biochim Biophys Acta Mol Basis Dis, 2018, 1864(4 Pt B):1468-1477.
[7]
Wang YF, Feng FL, Zhao XH, et al. Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer[J]. World J Gastroenterol, 2014, 20(14):4085-4092.
[8]
Spinelli A, Schumacher G, Pascher A, et al. Extended surgical resection for xanthogranulomatous cholecystitis mimicking advanced gallbladder carcinoma: a case report and review of literature[J]. World J Gastroenterol, 2006, 12(14):2293-2296.
[9]
Marrelli D, Caruso S, Pedrazzani C, et al. CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions[J]. Am J Surg, 2009, 198(3):333-339.
[10]
Lee T, Teng TZJ, Shelat VG. Carbohydrate antigen 19-9-tumor marker: past, present, and future[J]. World J Gastrointest Surg, 2020, 12(12):468-490.
[11]
Badea R, Zaro R, Opincariu I, et al. Ultrasound in the examination of the gallbladder - a holistic approach: grey scale, Doppler, CEUS, elastography, and 3D[J]. Med Ultrason, 2014, 16(4):345-355.
[12]
Gerstenmaier JF, Hoang KN, Gibson RN. Contrast-enhanced ultrasound in gallbladder disease: a pictorial review[J]. Abdom Radiol, 2016, 41(8):1640-1652.
[13]
Xie XH, Xu HX, Xie XY, et al. Differential diagnosis between benign and malignant gallbladder diseases with real-time contrast-enhanced ultrasound[J]. Eur Radiol, 2010, 20(1):239-248.
[14]
Zhang HP, Bai M, Gu JY, et al. Value of contrast-enhanced ultrasound in the differential diagnosis of gallbladder lesion[J]. World J Gastroenterol, 2018, 24(6):744-751.
[15]
Ramachandran A, Srivastava DN, Madhusudhan KS. Gallbladder cancer revisited: the evolving role of a radiologist[J]. Br J Radiol, 2021, 94(1117):20200726.
[16]
Ohtani T, Shirai Y, Tsukada K, et al. Spread of gallbladder carcinoma: CT evaluation with pathologic correlation[J]. Abdom Imaging, 1996, 21(3):195-201.
[17]
Kalra N, Gupta P, Singhal M, et al. Cross-sectional imaging of gallbladder carcinoma: an update[J]. J Clin Exp Hepatol, 2019, 9(3):334-344.
[18]
Schwartz LH, Black J, Fong Y, et al. Gallbladder carcinoma: findings at MR imaging with MR cholangiopancreatography[J]. J Comput Assist Tomogr, 2002, 26(3):405-410.
[19]
Albazaz R, Patel CN, Chowdhury FU, et al. Clinical impact of FDG PET-CT on management decisions for patients with primary biliary tumours[J]. Insights Imaging, 2013, 4(5):691-700.
[20]
Fogel EL, DeBellis M, McHenry L, et al. Effectiveness of a new long cytology brush in the evaluation of malignant biliary obstruction: a prospective study[J]. Gastrointest Endosc, 2006, 63(1):71-77.
[21]
Schoefl R, Haefner M, Wrba F, et al. Forceps biopsy and brush cytology during endoscopic retrograde cholangiopancreatography for the diagnosis of biliary stenoses[J]. Scand J Gastroenterol, 1997, 32(4):363-368.
[22]
徐庆成, 陈娟, 朱滢, 等. 内镜逆行胰胆管造影术在胆囊癌合并恶性梗阻性黄疸中的临床应用价值[J]. 中国内镜杂志, 2022, 28(8):74-78.
[23]
Hijioka S, Hara K, Mizuno N, et al. Diagnostic yield of endoscopic retrograde cholangiography and of EUS-guided fine needle aspiration sampling in gallbladder carcinomas[J]. J Hepatobiliary Pancreat Sci, 2012, 19(6):650-655.
[24]
Abdelghani YA, Arisaka Y, Masuda D, et al. Bile aspiration cytology in diagnosis of bile duct carcinoma: factors associated with positive yields[J]. J Hepatobiliary Pancreat Sci, 2012, 19(4):370-378.
[25]
Shotton R, Lamarca A, Valle J, et al. Potential utility of liquid biopsies in the management of patients with biliary tract cancers: a review[J]. World J Gastrointest Oncol, 2021, 13(9):1073-1085.
[26]
王楚风, 蒋安. 原发性肝癌的分子诊断[J/OL]. 中华肝脏外科手术学电子杂志, 2023, 12(5):499-503.
[27]
Salvi S, Gurioli G, de Giorgi U, et al. Cell-free DNA as a diagnostic marker for cancer: current insights[J]. Onco Targets Ther, 2016, 9: 6549-6559.
[28]
Han X, Wang J, Sun Y. Circulating tumor DNA as biomarkers for cancer detection[J]. Genomics Proteomics Bioinformatics, 2017, 15(2):59-72.
[29]
Zill OA, Greene C, Sebisanovic D, et al. Cell-free DNA next-generation sequencing in pancreatobiliary carcinomas[J]. Cancer Discov, 2015, 5(10):1040-1048.
[30]
Kumari S, Husain N, Agarwal A, et al. Diagnostic value of circulating free DNA integrity and global methylation status in gall bladder carcinoma[J]. Pathol Oncol Res, 2019, 25(3):925-936.
[31]
Ignatiadis M, Sledge GW, Jeffrey SS. Liquid biopsy enters the clinic-implementation issues and future challenges[J]. Nat Rev Clin Oncol, 2021, 18: 297-312.
[32]
Driescher C, Fuchs K, Haeberle L, et al. Bile-based cell-free DNA analysis is a reliable diagnostic tool in pancreatobiliary cancer[J]. Cancers, 2020, 13(1):39.
[33]
Shen N, Zhang D, Yin L, et al. Bile cell-free DNA as a novel and powerful liquid biopsy for detecting somatic variants in biliary tract cancer[J]. Oncol Rep, 2019, 42(2):549-560.
[34]
Jusakul A, Khuntikeo N, Haigh W, et al. Identification of biliary bile acids in patients with benign biliary diseases, hepatocellular carcinoma and cholangiocarcinoma[J]. Asian Pac J Cancer Prev, 2012, 13 Suppl:77-82.
[35]
闫甲, 刘双池, 王政宇. 胆囊癌肿瘤标志物的研究和应用进展[J/OL]. 中华普通外科学文献(电子版), 2023, 17(5):391-394.
[1] 王廷睿, 明佳. 循环肿瘤细胞的检测及其在乳腺癌中的临床应用[J]. 中华乳腺病杂志(电子版), 2024, 18(02): 114-118.
[2] 张腾花, 尚培中, 王晓梅, 李晓武, 王金, 苗建军, 刘冰. 外伤性脾破裂三阶梯分层治疗策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 510-512.
[3] 江杰, 沈城, 潘永昇, 陈新风, 刘振民, 朱华, 郑兵. 尿酸结石的危险因素分析及双能量CT特征研究[J]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 361-365.
[4] 赵智勇, 闫玉昌, 关磊, 金淑溶, 潘振宇. 多层螺旋CT并多平面重建技术在非裂孔性膈疝与膈膨升术前诊断中的应用[J]. 中华疝和腹壁外科杂志(电子版), 2024, 18(02): 228-233.
[5] 孙志红, 庞红艳, 王睿. 呼出气体中VOCs联合CT征象诊断非实性肺结节的临床意义[J]. 中华肺部疾病杂志(电子版), 2024, 17(03): 442-445.
[6] 谭明超, 龚明福, 陈佳, 张曦, 孙雅娟. 依据影像学特征的原发性肺类癌的分型及鉴别意义[J]. 中华肺部疾病杂志(电子版), 2024, 17(02): 218-222.
[7] 贾乃龙, 李传资, 王绥煌, 张余鹏, 林志华, 林昌昆, 黄垂志. 低剂量能谱CT结合多平面重建技术对肺癌和肺炎性结节鉴别诊断意义[J]. 中华肺部疾病杂志(电子版), 2024, 17(02): 247-251.
[8] 杨智義, 赵成俊, 胡欣芫, 潘佰猛, 张秋雨, 张挽乾, 曹芮, 张灵强. 外周血cfDNA液体活检技术在肝棘球蚴病诊治中的应用进展[J]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 389-393.
[9] 胡欣芫, 杨智義, 赵成俊, 张秋雨, 张挽乾, 潘佰猛, 张灵强. 急性胰腺炎评分系统预测病情严重程度的研究进展[J]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 239-243.
[10] 马振威, 朱博, 刘赋斌, 邓正栋, 王剑明. 血小板和淋巴细胞比值联合CA19-9在胆囊癌术后患者预后评估中的价值[J]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 163-168.
[11] 刘蕊, 李乐, 陈金明, 李鑫. 急性胆管炎严重程度与血清标志物相关性的Meta分析[J]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 176-181.
[12] 邵文哲, 孙倩男, 王道荣. Galectin-9在结直肠癌中的表达及其临床意义[J]. 中华结直肠疾病电子杂志, 2024, 13(02): 112-120.
[13] 赵迪, 杨鑫鑫, 孟宏学. 液体活检技术在结直肠癌诊疗领域的应用[J]. 中华结直肠疾病电子杂志, 2024, 13(02): 135-140.
[14] 赵浩, 尚峰, 程玮涛, 徐跃峤, 齐猛, 蒋丽丹, 陈文劲, 王宁, 曲鑫. 神经外科围术期瞳孔改变的相关因素分析[J]. 中华神经创伤外科电子杂志, 2024, 10(03): 147-150.
[15] 刘伟, 高续, 谢玉海, 蒋哲, 刘士成. 基于增强CT影像组学模型在预测急性胰腺炎复发中的应用价值[J]. 中华消化病与影像杂志(电子版), 2024, 14(04): 348-354.
阅读次数
全文


摘要